Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaolin Wang

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Analytical Biochemistry|July 13, 2004
Fluorescence polarization assay and inhibitor design for MDM2/p53 interactionRumin Zhang, Todd Mayhood, Philip Lipari, et al.
ACS Catalysis|April 17, 2020
Solar-Enhanced Plasma-Catalytic Oxidation of Toluene over a Bifunctional Graphene Fin Foam Decorated with Nanofin-like MnO<sub>2</sub>Zheng Bo, Shiling Yang, Jing Kong, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2014
Core modification of substituted piperidines as novel inhibitors of HDM2-p53 protein-protein interactionWeidong Pan, Brian R Lahue, Yao Ma, et al.
Cancer Research|October 6, 2005
ATM and p21 cooperate to suppress aneuploidy and subsequent tumor developmentKate C Shen, Henry Heng, Yaolin Wang, et al.
Journal of the American Chemical Society|June 22, 2022
Shielding Protection by Mesoporous Catalysts for Improving Plasma-Catalytic Ambient Ammonia SynthesisYaolin Wang, Wenjie Yang, Shanshan Xu, et al.
Drug Design, Development and Therapy|May 2, 2022
Effect of Systemic Lidocaine on Postoperative Early Recovery Quality in Patients Undergoing Supratentorial Tumor ResectionKai Zhao, Yushan Dong, Gaowei Su, et al.
Nature Communications|May 17, 2025
Shielded bifunctional nanoreactor enabled tandem catalysis for plasma methane couplingChunqiang Lu, Yaolin Wang, Dong Tian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pivotal Role of an Aliphatic Side Chain in the Development of an HDM2 InhibitorYao Ma, Brian R Lahue, Craig R Gibeau, et al.
Molecular Cancer Therapeutics|February 4, 2010
A fully human insulin-like growth factor-I receptor antibody SCH 717454 (Robatumumab) has antitumor activity as a single agent and in combination with cytotoxics in pediatric tumor xenograftsYaolin Wang, Philip Lipari, Xiaoying Wang, et al.
ACS Catalysis|February 12, 2026
Oxygen-Vacancy-Engineered Pd-WO<sub>3-<i>x</i></sub> for Enhanced Plasma-Catalyzed CO<sub>2</sub> Hydrogenation to COCan Cheng, Yaolin Wang, Jia-Nan Wang, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Analytical Biochemistry|July 13, 2004
Fluorescence polarization assay and inhibitor design for MDM2/p53 interactionRumin Zhang, Todd Mayhood, Philip Lipari, et al.
ACS Catalysis|April 17, 2020
Solar-Enhanced Plasma-Catalytic Oxidation of Toluene over a Bifunctional Graphene Fin Foam Decorated with Nanofin-like MnO<sub>2</sub>Zheng Bo, Shiling Yang, Jing Kong, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2014
Core modification of substituted piperidines as novel inhibitors of HDM2-p53 protein-protein interactionWeidong Pan, Brian R Lahue, Yao Ma, et al.
Cancer Research|October 6, 2005
ATM and p21 cooperate to suppress aneuploidy and subsequent tumor developmentKate C Shen, Henry Heng, Yaolin Wang, et al.
Journal of the American Chemical Society|June 22, 2022
Shielding Protection by Mesoporous Catalysts for Improving Plasma-Catalytic Ambient Ammonia SynthesisYaolin Wang, Wenjie Yang, Shanshan Xu, et al.
Drug Design, Development and Therapy|May 2, 2022
Effect of Systemic Lidocaine on Postoperative Early Recovery Quality in Patients Undergoing Supratentorial Tumor ResectionKai Zhao, Yushan Dong, Gaowei Su, et al.
Nature Communications|May 17, 2025
Shielded bifunctional nanoreactor enabled tandem catalysis for plasma methane couplingChunqiang Lu, Yaolin Wang, Dong Tian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pivotal Role of an Aliphatic Side Chain in the Development of an HDM2 InhibitorYao Ma, Brian R Lahue, Craig R Gibeau, et al.
Molecular Cancer Therapeutics|February 4, 2010
A fully human insulin-like growth factor-I receptor antibody SCH 717454 (Robatumumab) has antitumor activity as a single agent and in combination with cytotoxics in pediatric tumor xenograftsYaolin Wang, Philip Lipari, Xiaoying Wang, et al.
ACS Catalysis|February 12, 2026
Oxygen-Vacancy-Engineered Pd-WO<sub>3-<i>x</i></sub> for Enhanced Plasma-Catalyzed CO<sub>2</sub> Hydrogenation to COCan Cheng, Yaolin Wang, Jia-Nan Wang, et al.
Pageof 7